Buy DelMar Pharma Stock | DMPI Stock Price & Latest News | Public.com
DMPI

DelMar Pharma

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View DelMar Pharma (DMPI) stock trends here

    About DMPI

    Kintara Therapeutics, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. Its pipeline includes the VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and Willi...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.44
    -0.89
    -1.33
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.33

    Actual EPS
    Q3 2020

    -$1.33

    Stats

    Market Cap$56,65M
    Volume349,02k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.35
    1 Year Low$0.38
    Open$1.76
    High$1.86
    Low$1.50

    Buy any stock with any amount of money.

    Download the App
    Download the app